Beijing Nuokangda Pharmaceutical Technology Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 310

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Latest Deal Amount
  • $24.7M

  • Investors
  • 11

Beijing Nuokangda Pharmaceutical Technology General Information

Description

Provider of product upgrade and technology development services for pharmaceutical companies. The company focuses on research and development activities related to pharmaceuticals, accessories, medical equipment and supplies and other pharmaceutical-related areas, intending to offer customized pharmaceutical solutions and build China's first pharmaceutical R&D supermarket.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • No. 21, Rongxing North 1st Street
  • Beijing Economic and Technological Development Zone
  • Beijing, 100176
  • China
+86 010
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • No. 21, Rongxing North 1st Street
  • Beijing Economic and Technological Development Zone
  • Beijing, 100176
  • China
+86 010

Beijing Nuokangda Pharmaceutical Technology Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beijing Nuokangda Pharmaceutical Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Secondary Transaction - Private 11-Nov-2023 $24.7M Completed Profitable
10. IPO 20-Jul-2023 Cancelled Profitable
9. Later Stage VC (Series D) 05-Jun-2022 Completed Profitable
8. Secondary Transaction - Private 01-Oct-2021 Completed Profitable
7. Secondary Transaction - Private 26-Aug-2021 Completed Profitable
6. Secondary Transaction - Private 28-Aug-2020 Completed Profitable
5. Later Stage VC (Series C) 23-Jun-2020 Completed Profitable
4. IPO 24-Jul-2019 Cancelled Profitable
3. Secondary Transaction - Private 01-Nov-2017 $28M Completed Profitable
2. Early Stage VC (Series B) 01-Mar-2017 $23.3M $28M Completed Profitable
To view Beijing Nuokangda Pharmaceutical Technology’s complete valuation and funding history, request access »

Beijing Nuokangda Pharmaceutical Technology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 4,800,039 $4.96 $4.96 $4.96 6.8%
Ordinary 857,100 $5.21 $5.21 $5.21 1.21%
To view Beijing Nuokangda Pharmaceutical Technology’s complete cap table history, request access »

Beijing Nuokangda Pharmaceutical Technology Patents

Beijing Nuokangda Pharmaceutical Technology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-2023064714-A Hydrophilic injection-type skin filling composition, and preparation method and application thereof Active 26-Oct-2021
JP-7604433-B2 Hydrophilic injectable dermal filler composition and its preparation method and use Active 26-Oct-2021
JP-2024508482-A In-situ drug-loaded hydrogel and its preparation method and use Active 31-Mar-2021
JP-7623515-B2 In-situ drug-loaded hydrogels and their preparation and use Active 31-Mar-2021 A61K47/34

Beijing Nuokangda Pharmaceutical Technology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Beijing Nuokangda Pharmaceutical Technology Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Keyuan Pharma Corporation Minority
CloudView Capital PE/Buyout Minority
Alan Asset Management Venture Capital Minority
Shanghai Passion Capital PE/Buyout Minority
Zhejiang Sanhua Refrigeration Group Corporation Minority
You’re viewing 5 of 11 investors. Get the full list »

Beijing Nuokangda Pharmaceutical Technology FAQs

  • When was Beijing Nuokangda Pharmaceutical Technology founded?

    Beijing Nuokangda Pharmaceutical Technology was founded in 2013.

  • Where is Beijing Nuokangda Pharmaceutical Technology headquartered?

    Beijing Nuokangda Pharmaceutical Technology is headquartered in Beijing, China.

  • What is the size of Beijing Nuokangda Pharmaceutical Technology?

    Beijing Nuokangda Pharmaceutical Technology has 310 total employees.

  • What industry is Beijing Nuokangda Pharmaceutical Technology in?

    Beijing Nuokangda Pharmaceutical Technology’s primary industry is Drug Discovery.

  • Is Beijing Nuokangda Pharmaceutical Technology a private or public company?

    Beijing Nuokangda Pharmaceutical Technology is a Private company.

  • What is Beijing Nuokangda Pharmaceutical Technology’s current revenue?

    The current revenue for Beijing Nuokangda Pharmaceutical Technology is .

  • How much funding has Beijing Nuokangda Pharmaceutical Technology raised over time?

    Beijing Nuokangda Pharmaceutical Technology has raised $63.7M.

  • Who are Beijing Nuokangda Pharmaceutical Technology’s investors?

    Keyuan Pharma, CloudView Capital, Alan Asset Management, Shanghai Passion Capital, and Zhejiang Sanhua Refrigeration Group are 5 of 11 investors who have invested in Beijing Nuokangda Pharmaceutical Technology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »